BNBX vs SRPT · P/E 0.0, rev $2.2M vs rev $1.13B
Applied DNA Sciences, Inc. (BNBX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Applied DNA Sciences, Inc. (BNBX) is a asset management company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported BNBX revenue for 2026-06-30 was $2.2M. Net income was -$29.9M. Revenue was up 38.1% from 2026-03-31 to 2026-06-30. BNBX currently screens at market cap $3.3M and trailing P/E 0.0.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
BNBX currently screens at market cap $3.3M and trailing P/E 0.0. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the BNBX and SRPT stock pages for the full models.
Not investment advice.